EAST MILLSTONE, N.J.--(BUSINESS WIRE)--Aug. 7, 2006-- Life Sciences Research, Inc. (OTC:LSRI - Life Sciences Research, Inc. (OTC:LSRI - News) announced today that revenues for the quarter ended June 30, 2006 were $47.9 million, 6.5% above the revenues for the same period in the prior year of $44.9 million. Excluding the effect of exchange rate movements, revenues increased 7.7%. Operating income for the quarter ended June 30, 2006 was $4.8 million, or 10.1% of revenues, compared with $5.4 million, or 12.0% of revenues for the same period in the prior year. The Company reported net income before the cumulative effect of the accounting change for the quarter ended June 30, 2006 of $1.1 million, compared with $1.7 million loss for the quarter ended June 30, 2005. Net income per common share before the cumulative effect of the accounting change for the quarter ended June 30, 2006 was $0.09 compared with $0.13 loss in the quarter ended June 30, 2005. Net income per fully diluted share before the cumulative effect of the accounting change was $0.08 for the current quarter compared to $0.11 loss in the prior year.
